Rankings
▼
Calendar
IOVA Q2 2021 Earnings — Iovance Biotherapeutics, Inc. Revenue & Financial Results | Market Cap Arena
IOVA
Iovance Biotherapeutics, Inc.
$2B
Q2 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$81M
Net Income
-$81M
EPS (Diluted)
$-0.53
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$54M
Free Cash Flow
-$64M
Stock-Based Comp.
$14M
Balance Sheet
Total Assets
$853M
Total Liabilities
$108M
Stockholders' Equity
$744M
Cash & Equivalents
$83M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$81M
-$64M
-28.0%
Net Income
-$81M
-$63M
-29.1%
← FY 2021
All Quarters
Q3 2021 →